Massivemarkets

Nasdaq: ODTX · IPO announced

Odyssey Therapeutics IPO

$18.98

15-minute delayed · as of 4:20:00 PM EST on Nov 18, 2026

Odyssey Therapeutics (ODTX) announced an IPO on Jan 17, 2025. The price range is not set. The listing date is not set.

Last session · Nov 18, 2026

VWAP 19.24open 19.26fell below the open · 11:15back above the open · 11:20fell below the open · 2:50high 19.81low 18.82$18.95volume · rising bars above the line, falling bars below22.43K9:304:00
Market cap
$912.33M
from the ticker reference
Volume
302.03K
shares, regular session
VWAP
$19.24
the last price is -1.37% from the volume-weighted average
Day range
18.81–19.98
low to high

The trading numbers are from the last session, Nov 18, 2026.

The offering

The terms of the Odyssey Therapeutics IPO.

Exchange
Nasdaq
Security
Ordinary Shares

Where ODTX ranks

Odyssey Therapeutics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • ODTX$912.33M

Filings and the company

What Odyssey Therapeutics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Odyssey Therapeutics discloses to the SEC on Form 8-K.

  • On November 4, 2026, Odyssey Therapeutics, Inc. (the "Company") announced its financial results for the three months ended September 30, 2026.

  • Investor presentationOct 20, 2026

    The Company issued the press release and “posted a corporate presentation on its website at https://investors.odysseytx.com/news-events/presentations.”

  • Investor presentationSep 9, 2026

    On September 8, 2026, Odyssey Therapeutics, Inc. (the "Company") posted a corporate presentation on its website at https://investors.odysseytx.com/news-events/presentations. A copy of the presentation is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.

  • Investor presentationJun 23, 2026

    On June 23, 2026, Odyssey Therapeutics, Inc. (the "Company") posted a corporate presentation on its website at https://investors.odysseytx.com/news-events/presentations. A copy of the presentation is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.

  • Charter amendmentMay 11, 2026

    In connection with the closing of the IPO, on May 11, 2026, the Company filed an amended and restated certificate of incorporation with the Secretary of State of the State of Delaware. The Company's board of directors and stockholders previously approved the Amended and Restated Certificate of Incorporation to be effective as of immediately prior to the closing of the IPO.

About Odyssey Therapeutics

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Ticker
ODTX
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
May 8, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What is the Odyssey Therapeutics IPO price?

It is not set. No price range is public yet.

When does Odyssey Therapeutics (ODTX) start trading?

The listing date for ODTX is not set.

Are the prices on this page real time?

No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.

Build with Massive

Get the ODTX data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/ODTX/range/5/minute
Market cap/v3/reference/tickers/ODTX
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.